| 前收市價 | 1.7500 |
| 開市 | 1.7600 |
| 買盤 | 1.7000 x 100 |
| 賣出價 | 1.8500 x 100 |
| 今日波幅 | 1.7301 - 1.8089 |
| 52 週波幅 | 1.5900 - 22.0000 |
| 成交量 | |
| 平均成交量 | 1,144,617 |
| 市值 | 3.682M |
| Beta 值 (5 年，每月) | 0.28 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -25.2600 |
| 業績公佈日 | 2024年8月13日 - 2024年8月19日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 20.00 |
ZacksBio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
Bio-Path (BPTH) gains 30% on encouraging developmental updates from the early-stage study of its investigational candidate, BP1002, to treat acute myeloid leukemia patients.
Insider MonkeyBio-Path Holdings, Inc. (NASDAQ:BPTH) Q4 2023 Earnings Call Transcript
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q4 2023 Earnings Call Transcript March 8, 2024 Bio-Path Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to the Bio-Path Holdings Full Year 2023 Earnings Conference Call. […]
Insider MonkeyBio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2023 Earnings Call Transcript
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2023 Earnings Call Transcript November 15, 2023 Operator: Good morning, ladies and gentlemen. Welcome to the Bio-Path Holdings Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Following the formal remarks, we will open the call up for your questions. Please […]
